Primer: assessing the efficacy and safety of nonpharmacologic treatments for chronic rheumatic diseases (Q36577498)

15 August 2017

1 reference

title

Primer: assessing the efficacy and safety of nonpharmacologic treatments for chronic rheumatic diseases (English)

1 reference

15 August 2017

Isabelle Boutron

2

0 references

Philippe Ravaud

object named as

Philippe Ravaud

series ordinal

1

0 references

publication date

1 June 2006

1 reference

Nature Clinical Practice Rheumatology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

6

1 reference

15 August 2017

313-319

1 reference

Understanding controlled trials. What is a patient preference trial?

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

21 January 2018

What is Zelen's design?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

Randomised controlled trial of exercise for low back pain: clinical outcomes, costs, and preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

Neurologic complications following chiropractic manipulation: a survey of California neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

Reporting of Harm in Randomized, Controlled Trials of Nonpharmacologic Treatment for Rheumatic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

Secular changes in the quality of published randomized clinical trials in rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Methodological Differences in Clinical Trials Evaluating Nonpharmacological and Pharmacological Treatments of Hip and Knee Osteoarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

The role of randomization in clinical studies: myths and beliefs

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Comparison of evidence of treatment effects in randomized and nonrandomized studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Effect of external hip protectors on hip fractures

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Impact of participant and physician intervention preferences on randomized trials: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Are randomized controlled trials controlled? Patient preferences and unblind trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Adapting the randomized consent (Zelen) design for trials of behavioural interventions for chronic disease: feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Randomised consent trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Randomised consent designs in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Trials and fast changing technologies: the case for tracker studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Need for expertise based randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

1 reference

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

A controlled trial of arthroscopic surgery for osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Tidal irrigation as treatment for knee osteoarthritis: a sham-controlled, randomized, double-blinded evaluation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Introducing a placebo needle into acupuncture research

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Characteristic and incidental (placebo) effects in complex interventions such as acupuncture

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

The validity and ethics of giving placebo in a randomized nonpharmacologic trial was evaluated

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

The methods for handling missing data in clinical trials influence sample size requirements

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Analyzing incomplete longitudinal clinical trial data

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Framework for design and evaluation of complex interventions to improve health

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Analysis of quality of interventions in systematic reviews

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Variations in morbidity after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Interpretation of operative risks of individual surgeons. European Carotid Surgery Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Does it matter what a hospital is "high volume" for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Assessment of the learning curve in health technologies. A systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Prospective investigations into the safety of spinal manipulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Adverse effects of acupuncture

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

The hazards of scoring the quality of clinical trials for meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

A systematic review of the content of critical appraisal tools

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

1 reference

7 January 2021

Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Volume of procedures and outcome of treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0194

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0194

1 reference

15 August 2017

1 reference

PubMed ID

16932710